Document is current

Any future updates will be listed below

Tumor burden monitoring using cell-free tumor DNA could be limited by tumor heterogeneity in advanced breast cancer and should be evaluated together with radiographic imaging

Crossref DOI link: https://doi.org/10.1186/s12885-017-3185-9

Published Online: 2017-03-22

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark